To compare the clinical comprehensive value of gonadotropin-releasing hormone analogue (GnRHa) formulations (triptorelin versus leuprolide) in the treatment of central precocious puberty (CPP), in order to provide reference for clinical rational drug use and essential drug access decision-making.
According to the guidelines, a clinical comprehensive evaluation indicator system for GnRHa treatment of CPP was constructed through literature review, expert survey and expert argumentation. The weights of each indicator were determined by analytic hierarchy process. Systematic literature review, meta-analysis and other relevant data material analysis were utilized to perform qualitative and quantitative integrated analysis for each dimension and each indicator of the two GnRHa formulations.
Five first-level indicators, six second-level indicators and fourteen third-level indicators were constructed. The weights of safety, effectiveness, economy, appropriateness and accessibility were 0.59, 0.11, 0.12, 0.10, and 0.08, respectively. The overall score of triptorelin (63.68 points) was higher than that of leuprolide (56.38 points).
Compared with the leuprolide regimen for CPP treatment, triptorelin has obvious advantages in economy and effectiveness, and thus its clinical comprehensive value is higher than leuprolide regimen.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |